SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-070335
Filing Date
2024-08-16
Accepted
2024-08-16 17:25:41
Documents
22
Period of Report
2024-08-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.06: Change in Shell Company Status
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0211423-8k_citius.htm   iXBRL 8-K 156798
2 CERTIFICATE OF INCORPORATION OF CITIUS ONCOLOGY, INC ea021142301ex3-1_citius.htm EX-3.1 41349
3 BYLAWS OF CITIUS ONCOLOGY, INC ea021142301ex3-2_citius.htm EX-3.2 163631
4 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT, DATED AS OF AUGUST 12, 2024 ea021142301ex10-1_citius.htm EX-10.1 126336
5 AMENDED AND RESTATED SHARED SERVICES AGREEMENT, DATED AS OF AUGUST 12, 2024, BY ea021142301ex10-2_citius.htm EX-10.2 64959
6 SIDE LETTER AGREEMENT, DATED AUGUST 12, 2024, BY AND BY AND AMONG CITIUS PHARMAC ea021142301ex10-8_citius.htm EX-10.8 19584
7 PROMISSORY NOTE, DATED AUGUST 16, 2024, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND ea021142301ex10-9_citius.htm EX-10.9 19277
8 LETTER FROM MARCUM LLP TO THE SECURITIES AND EXCHANGE COMMISSION, DATED AUGUST 1 ea021142301ex16-1_citius.htm EX-16.1 2504
9 SUBSIDIARIES OF CITIUS ONCOLOGY, INC ea021142301ex21-1_citius.htm EX-21.1 1768
  Complete submission text file 0001213900-24-070335.txt   947204

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE tenku-20240812.xsd EX-101.SCH 3267
11 XBRL DEFINITION FILE tenku-20240812_def.xml EX-101.DEF 26193
12 XBRL LABEL FILE tenku-20240812_lab.xml EX-101.LAB 35952
13 XBRL PRESENTATION FILE tenku-20240812_pre.xml EX-101.PRE 24851
24 EXTRACTED XBRL INSTANCE DOCUMENT ea0211423-8k_citius_htm.xml XML 5438
Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017 (347) 627-0058
CITIUS ONCOLOGY, INC. (Filer) CIK: 0001851484 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41534 | Film No.: 241217674
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)